Stock listing

Gyre Therapeutics, Inc.

Selected listing: A3EE5F · LS · EUR · DE

Gyre Therapeutics, Inc. (Lang & Schwarz: A3EE5F), Health Technology. Latest release Sep 3, 2026: Gyre Therapeutics to Participate in Upcoming September…

A3EE5F:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A3EE5F
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Gyre Therapeutics, Inc.

Gyre Therapeutics to Participate in Upcoming September Investor Conferences

September 3, 2026

Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update

August 7, 2026

Gyre Therapeutics Appoints Three New Members to its Board of Directors

July 16, 2026

Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment

May 12, 2026

Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update

May 7, 2026

All Gyre Therapeutics, Inc. news →

Research Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc. company profile

View the public company page for Gyre Therapeutics, Inc. on 6ix.

Gyre Therapeutics, Inc. news

Read company news and market updates connected to Gyre Therapeutics, Inc..

Gyre Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Gyre Therapeutics, Inc..